Navigation Links
Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
Date:7/12/2011

IL-6 inhibition.  The incidence of serious adverse events among the five sarilumab treatment groups and placebo group were comparable.

Sarilumab also demonstrated significant benefit compared to placebo in secondary endpoints, including ACR 50, ACR 70, and DAS 28 scores, additional measures of clinical activity used in RA trials.  

"Following these encouraging Phase 2b results in rheumatoid arthritis, the companies are currently discussing the dose(s) of sarilumab to advance into the Phase 3 portion of the MOBILITY  trial," said Elias Zerhouni, President, Global Research & Development, Sanofi.

"The MOBILITY results provide evidence that IL-6R blockade with sarilumab represents a promising new anti-inflammatory investigational therapy for reducing RA disease symptoms.  We are very pleased that the first of our novel VelocImmune® derived antibodies is poised to enter Phase 3 development," said George D. Yancopoulos, M.D., Ph.D., Chief Scientific Officer of Regeneron and President of Regeneron Research Laboratories.

In the Phase 2b ALIGN trial in ankylosing spondylitis (AS), sarilumab did not demonstrate significant and clinically meaningful improvements in signs and symptoms of active AS compared to placebo in patients who had inadequate response to NSAIDs.  Sarilumab was generally well tolerated. The most common adverse events reported more frequently in active treatment arms included infections and neutropenia.

Full data of both Phase 2b trials will be submitted for presentation at an upcoming scientific conference.

About SarilumabSarilumab (REGN88/ SAR153191) is the first fully human monoclonal antibody directed against the alpha subunit of the IL-6 receptor complex (IL-6R alpha).  Sarilumab is a high affinity, sub-cutaneously delivered, specific inhibitor of IL-6 signaling.  It blocks the binding of IL-6 to its receptor and interrupts the resultant cyto
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
2. Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
3. Sanofi Pasteur Commends Winners of International BioGENEius Challenge
4. Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen
5. Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
6. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
7. Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims
8. sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
9. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
10. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
11. Sanofi-Aventis Completes Acquisition of Genzyme Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)...  EHE International, the recognized leader in preventive medicine ... today announced that Dignity Health Medical Group Nevada, LLC  ... been named an EHE-certified preventive care center. Through Dignity, ... region now have greater access to EHE,s preventive ... "EHE is proud to add Dignity Health ...
(Date:7/21/2014)... 21, 2014 According ... Research "E-Clinical Solution Software Market- Global Industry Analysis, Size, ... global microfluidic device market was valued at USD 3,005 ... a CAGR of 13.8% from 2014 to 2020, to ... 2020. Browse the full E-Clinical Solution Software Market ...
(Date:7/21/2014)... -- By order of the U.S. Bankruptcy Court, Tiger Group,s ... and optical equipment, designer eyeglass frames, and other assets of ... Services LLC. Online bidding opens July 21 at ... auction style, on July 28 beginning at 10:30 a.m. (ET). ... July 25 th and 26 th at 12 ...
Breaking Medicine Technology:EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5Auction Set For Assets Of National Optical Services Company 2
... CAESAREA, Israel, May 2, 2012 Angioslide ... announced that it has received FDA 510(K) clearance for ... Disease in below the knee (BTK) vasculature.  The new ... potential use of PROTEUS technology.   Angioslide,s ...
... NBIX ) today announced its financial results for ... of 2012, the Company reported net loss of $0.9 million, ... of $2.9 million, or $0.05 income per share, for the ... results is primarily due to the Company,s VMAT2 program moving ...
Cached Medicine Technology:Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device 2Neurocrine Biosciences Reports First Quarter 2012 Results 2Neurocrine Biosciences Reports First Quarter 2012 Results 3Neurocrine Biosciences Reports First Quarter 2012 Results 4Neurocrine Biosciences Reports First Quarter 2012 Results 5Neurocrine Biosciences Reports First Quarter 2012 Results 6
(Date:7/22/2014)... July 22, 2014 The hair ... are now offering robotic assisted laser therapy and ... solutions for men and women suffering from hair ... they now offer Follicular Unit Extraction (FUE) procedures ... robot. With this new technology, their doctors use ...
(Date:7/21/2014)... to target and kill cancer cells could boost the ... help avoid amputation, a new study reports. , Scientists ... effectiveness of a genetically engineered version of the virus ... of the virus alongside isolated limb perfusion chemotherapy ... or leg as an alternative to amputation was ...
(Date:7/21/2014)... 2014 MillionaireCasket.com, a well-known casket manufacturer from ... caskets to its website. In addition to this, the ... off) for all these brand new items. , MillionaireCasket.com ... great caskets for its current and prospective clients. ... and oak caskets and more. According to the company’s sales ...
(Date:7/21/2014)... CA (PRWEB) July 21, 2014 Cannabis ... four major cannabis events this summer. During these festivals, ... by providing additional information and resources to attendees in ... educate the public on the legitimate and beneficial side ... Cannabis Cup in San Francisco, the Kush Expo in ...
(Date:7/21/2014)... to hate losing. , Unfortunately, it,s also human ... solid strategy and thus increasing your chances of losing ... a Brigham Young University study published this week by ... based on an analysis of two decades of data ... whether coaches adjusted their personnel following games where the ...
Breaking Medicine News(10 mins):Health News:WeGrowHair.com/PAI Medical Group Introduces Robotic Assisted Laser Therapy to Treat Hair Loss 2Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3Health News:Cheap Maple Caskets Recently Added To China Casket Manufacturer MillionaireCasket.com’s Product Line 2Health News:Cannabis Now Magazine Hits the Marijuana Festival Circuit and Sponsors Two Major Events 2Health News:'Moral victories' might spare you from losing again 2
... alcohol quotient is highly conducive for the cognitive development ... has suggested//. Infact, even moderated alcohol intake during the ... child. ,The study conducted by the University of ... has shown that those children, whose mothers had indulged ...
... Geneva – A nod has been given by the administration in ... research and development//. This is indeed a quantum leap in this ... it will also infuse renewed thrust in the area of drug ... novel methods to source drugs, based on the funding. ...
... some alarming world statistics regarding the use of tobacco amongst ... year olds consume tobacco and its products. , ,These ... World Health Organization's World No Tobacco Day; on May 31st. ... in any form or disguise,'' conveying cigarette smoking in any ...
... that nearly a third of the 32,000 terminations by women ... abortion pill, also known as EMA early medical abortion. ... abortion pill in Britain has reached an all time high ... the number of women, which it treated with EMA, rose ...
... students and junior medical doctors of the Medical College ... have decided to not to run the outpatient departments ... doctors have however promised not to cause any inconvenience ... a ‘parallel OPD’s’ for the benefit of patents. A ...
... much commotion across the world and it has drastically affected the ... increase in demand for chicken// and the sales are slowly picking ... in its recuperation stage. ,Mohamed Al Shafei, director of ... has suffered a great deal in the past with a large ...
Cached Medicine News:Health News:Record Number Of Women Use Abortion Pills 2Health News:Agitating Doctors Call For Two Day Shut Down Of OPD’ 2
0.5X1.5mm Tip, Oval Shape; in Titanium....
0.5X2.0mm Tip, Oval Shape; in Titanium....
2.5x8mm Spatula Combined with 8mm Blade; in stainless steel....
0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
Medicine Products: